DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "United States Glucose Monitoring Market Outlook to 2022" report to their offering.
The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Blood Glucose Meters, Blood Glucose Test Strips and Lancets.
The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
- Market size and company share data for Glucose Monitoring market segments - Blood Glucose Meters, Blood Glucose Test Strips and Lancets.
- Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for each of the market segements.
- Global corporate-level profiles of key companies operating within the United States Glucose Monitoring market.
- Key players covered include LifeScan Inc, Medtronic plc, Bayer HealthCare AG, F. Hoffmann-La Roche Ltd and Others.
Key Topics Covered:
1 Tables & Figures
3 Glucose Monitoring Market, United States
4 Overview of Key Companies in United States, Glucose Monitoring Market
5 Glucose Monitoring Market Pipeline Products
6 Financial Deals Landscape
7 Recent Developments
- LifeScan Inc
- Bayer HealthCare AG
- Abbott Laboratories
- DexCom Inc
- F. Hoffmann-La Roche Ltd
- Medtronic plc
- Becton Dickinson and Co
- Trividia Health Inc
- Arkray Inc
For more information about this report visit http://www.researchandmarkets.com/research/t6c2gt/united_states